IBIO SCHEDULE 13G/A: SEC filing
Frazier Life Sciences Public Fund, L.P. and affiliated entities
Filed with the SEC on · accession 0001231919-26-001582
IBIO filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. Frazier Life Sciences Public Fund, L.P. and affiliated entities filed an amended Schedule 13G reporting beneficial ownership of 1,953,467 shares, or 3.0%, of iBio, Inc.'s common stock as of September 30, 2026. The stock moved -3.4% by the first close after the filing.
Summary of the filing
Frazier Life Sciences Public Fund, L.P. and affiliated entities filed an amended Schedule 13G reporting beneficial ownership of 1,953,467 shares, or 3.0%, of iBio, Inc.'s common stock as of September 30, 2026. The filing also discloses holdings of pre-funded warrants to purchase additional shares, which are subject to a 9.99% beneficial ownership cap.
Key details
How IBIO stock reacted
Close before
$0.73
Nov 13, 2026
First close after
-3.42%
$0.71
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for IBIO, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for IBIO?
Click hereFrequently asked questions
What did IBIO file with the SEC on Nov 16, 2026?
IBIO filed a SCHEDULE 13G/A (SEC filing). Frazier Life Sciences Public Fund, L.P. and affiliated entities filed an amended Schedule 13G reporting beneficial ownership of 1,953,467 shares, or 3.0%, of iBio, Inc.'s common stock as of September 30, 2026. The filing also discloses holdings of pre-funded warrants to purchase additional shares, which are subject to a 9.99% beneficial ownership cap.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did IBIO stock react to this filing?
IBIO closed at $0.73 before the filing and $0.71 on Nov 16, 2026 (-3.42%).
Other IBIO SEC filings
Get alerts when IBIO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days